PMID- 21801323 OWN - NLM STAT- MEDLINE DCOM- 20120123 LR - 20191210 IS - 1752-699X (Electronic) IS - 1752-6981 (Linking) VI - 5 IP - 4 DP - 2011 Oct TI - Validation of the Finnish ISAAC questionnaire on asthma against anti-asthmatic medication reimbursement database in 5-year-old children. PG - 211-8 LID - 10.1111/j.1752-699X.2010.00222.x [doi] AB - BACKGROUND: Valid identification of childhood asthma at the population level for epidemiological purposes remains a challenge. We aimed at validating the Finnish version of the International Study of Asthma and Allergies in Childhood (ISAAC) questionnaire based on parental-reported childhood asthma. MATERIALS AND METHODS: The ISAAC questionnaire has been validated against anti-asthmatic medication reimbursement data of the Finnish Social Insurance Institution, being the gold standard, among 2236 5-year-old consecutively born children (1996-2004) carrying human leukocyte antigen (HLA)-conferred susceptibility to type 1 diabetes. Two combined questionnaire questions (any wheezing symptom or use of asthma medication during the preceding 12 months plus ever asthma; any wheezing symptom or use of asthma medication during the preceding 12 months plus ever doctor-diagnosed asthma) were validated against valid reimbursement with purchase of at least one anti-asthmatic medication during a 12-month period. The validity of the questionnaire was estimated as the sensitivity, specificity, positive predictive value, negative predictive value, and Youden's index. RESULTS: The sensitivity 0.98 [95% confidence interval (CI) = 0.92-0.99]; specificity 0.98 (95% CI = 0.97-0.98); negative predictive value 1.00 (95% CI = 1.00-1.00); and Youden's index 0.96 (95% CI = 0.96-0.96) were the same for each of the two sets of combined questions. The positive predictive value for the first combined question was 0.63 (95% CI = 0.55-0.71), while it was 0.64 (95% CI = 0.57-0.72) for the second combined question. CONCLUSION: The Finnish ISAAC questionnaire was highly valid and is an acceptable instrument for the survey of the prevalence of parental-reported childhood asthma for epidemiological purposes. CI - (c) 2010 Blackwell Publishing Ltd. FAU - Nwaru, Bright Ibeabughichi AU - Nwaru BI AD - Tampere School of Public Health, University of Tampere, Finland. bright.nwaru@uta.fi FAU - Lumia, Mirka AU - Lumia M FAU - Kaila, Minna AU - Kaila M FAU - Luukkainen, Paivi AU - Luukkainen P FAU - Tapanainen, Heli AU - Tapanainen H FAU - Erkkola, Maijaliisa AU - Erkkola M FAU - Ahonen, Suvi AU - Ahonen S FAU - Pekkanen, Juha AU - Pekkanen J FAU - Klaukka, Timo AU - Klaukka T FAU - Veijola, Riitta AU - Veijola R FAU - Simell, Olli AU - Simell O FAU - Knip, Mikael AU - Knip M FAU - Virtanen, Suvi Mirjami AU - Virtanen SM LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't PT - Validation Study DEP - 20100901 PL - England TA - Clin Respir J JT - The clinical respiratory journal JID - 101315570 RN - 0 (Anti-Asthmatic Agents) SB - IM MH - Anti-Asthmatic Agents/*therapeutic use MH - Asthma/diagnosis/drug therapy/*epidemiology MH - Child, Preschool MH - Female MH - Finland/epidemiology MH - Humans MH - Insurance, Health, Reimbursement/*statistics & numerical data MH - Male MH - Prevalence MH - *Surveys and Questionnaires EDAT- 2011/08/02 06:00 MHDA- 2012/01/24 06:00 CRDT- 2011/08/02 06:00 PHST- 2011/08/02 06:00 [entrez] PHST- 2011/08/02 06:00 [pubmed] PHST- 2012/01/24 06:00 [medline] AID - 10.1111/j.1752-699X.2010.00222.x [doi] PST - ppublish SO - Clin Respir J. 2011 Oct;5(4):211-8. doi: 10.1111/j.1752-699X.2010.00222.x. Epub 2010 Sep 1.